Uncategorized files

Jump to: navigation, search

Showing below up to 50 results in range #51 to #100.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

15C. PIPERACILLIN TAZOBACTAM KABI POWDER FOR SOLUTION FOR INJECTIONINFUSION (2G 0.25G)+(4G 0.5G) SPC 27M0131 2.pdf ; 275 KB
15D. TAZOCIN EF POWDER FOR SOLUTION FOR INFUSION (4G 0.5G)+(2G 0.25G)VIAL PL 9300220 3.pdf ; 222 KB
15D. TAZOCIN EF POWDER FOR SOLUTION FOR INFUSION (4G 0.5G)+(2G 0.25G)VIAL SPC 9300220 4.pdf ; 310 KB
15E. TAZOREX POWDER FOR SOLUTION FOR INJECTION (4G 0.5G)VIAL PL 2800186 2.pdf ; 302 KB
15E. TAZOREX POWDER FOR SOLUTION FOR INJECTION (4G 0.5G)VIAL SPC 2800186 2.pdf ; 312 KB
16A. CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION INFUSION 1G+2G PL 28M0103 2.pdf ; 199 KB
16A. CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION INFUSION 1G+2G SPC 28M0103 2.pdf ; 361 KB
16A. VANCO SAPIENS POWDER FOR SOLUTION FOR INFUSION 1G VIAL PL 3300244 3.pdf ; 353 KB
16A. VANCO SAPIENS POWDER FOR SOLUTION FOR INFUSION 1G VIAL SPC 3300244 3.pdf ; 417 KB
16B. DELTACEF POWDER FOR SOLUTION FOR INJECTION INFUSION 500MG+1G+2GVIAL PL 2800104 4.pdf ; 226 KB
16B. DELTACEF POWDER FOR SOLUTION FOR INJECTION INFUSION 500MG+1G+2GVIAL SPC 2800104 4.pdf ; 235 KB
16B. VANCOMYCIN MYLAN POWDER FOR SUSPENSION FOR INFUSION 500MG+1G VIAL PL 30M0095 2.pdf ; 256 KB
16B. VANCOMYCIN MYLAN POWDER FOR SUSPENSION FOR INFUSION 500MG+1G VIAL SPC 30M0095 2.pdf ; 309 KB
16C. PIMAXEF POWDER FOR SOLUTION FOR INJECTION+INFUSION 500MG+1G+2GVIAL PL 3600040 1.pdf ; 312 KB
16C. PIMAXEF POWDER FOR SOLUTION FOR INJECTION+INFUSION 500MG+1G+2GVIAL SPC 3600040 1.pdf ; 239 KB
16C. VANCOMYCIN WOCKHARDT POWDER FOR SOLUTION FOR INTRAVENOUS INFUSION OR ORAL USE 1GVIAL PL 29S0091 6.pdf ; 701 KB
1A. KALETRA TABLET, FILM COATED 200MG 50MG-epar-product-information en.pdf ; 834 KB
2.PNG 975 × 795; 56 KB
2. Vitamin C Arena 750 mg solution for injection PL 37S0047 2.pdf ; 118 KB
2A. CHLOROQUINE PHOSPHATE TABLET, COATED 250MG PL 8800478 5.pdf ; 255 KB
2A. CHLOROQUINE PHOSPHATE TABLET, COATED 250MG SPC 8800478 4.pdf ; 172 KB
3.PNG 945 × 216; 20 KB
3. OLUMIANT TABLET, FILM COATED 2mg+4mg SPC+PIL.pdf ; 349 KB
3A. HYDROXYCHLOROQUINE SULFATE TABLET, FILM COATED 200MG PL 31S0086 4.pdf ; 32 KB
3B. PLAQUENIL TABLET, FILM COATED 200MG PL 36S0006 1.pdf ; 111 KB
3a.PNG 2,594 × 816; 154 KB
4.10 Vital Signs graph.PNG 874 × 462; 62 KB
4.11 PaO2 FiO2 SpO2 graphs.PNG 904 × 265; 48 KB
4.12 Vital Signs Daily Monitoring.png 1,462 × 546; 52 KB
4.13 Arterial Blood Gases Daily Monitoring.png 1,461 × 560; 41 KB
4.14 Infection related indices.png 1,457 × 239; 14 KB
4.15 Coagulation fuction Daily Monitoring.png 1,458 × 241; 9 KB
4.16 Glasgow Measures Daily Monitoring.png 1,457 × 497; 41 KB
4.17 Medication Mediation and Treatment.PNG 1,215 × 434; 24 KB
4.18 Add Medication Medication and Treatment.PNG 531 × 424; 17 KB
4.19 Treatment Medication and Treatment.PNG 1,183 × 507; 24 KB
4.1 Patient Demographics and Status.PNG 1,764 × 144; 29 KB
4.20 Comorbidities and Allergies.PNG 1,204 × 640; 55 KB
4.20 a Comorbidities and Allergies add allergy.PNG 535 × 325; 10 KB
4.21 Symptoms.PNG 1,211 × 405; 21 KB
4.21 a Symptoms Update symptoms.PNG 536 × 796; 23 KB
4.22 Hematologic Laboratory.PNG 1,185 × 450; 22 KB
4.23 Biochemical Laboratory.PNG 1,182 × 524; 28 KB
4.24 Demographics Contact person.png 1,481 × 939; 88 KB
4.25 ards mews glasgow.png 838 × 284; 30 KB
4.26 Comorbidities Social History.png 698 × 517; 52 KB
4.27 Allergies.png 694 × 861; 59 KB
4.28 drug allergy choices.png 449 × 153; 12 KB
4.29 drug allergy agent choices.png 442 × 147; 7 KB
4.2 Change patient outcome.PNG 535 × 312; 8 KB

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://covid19-wiki.ehealthlab.cs.ucy.ac.cy/index.php/Special:UncategorizedFiles"